Track drugmakers, diagnostics, hospitals, and medical equipment firms.
Name | Price (Rs) | Market Cap (Rs Cr) | ROE (%) | ROCE (%) | Debt/Eq (x) | Sales var 3yrs (%) | Profit var 3yrs (%) | P/E (x) | P/BV (x) | EV/EBITDA (x) | |
---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries | 1,581.60 | 3,79,478.82 | 15.13 | 19.83 | 0.03 | 10.80 | 13.97 | 36.59 | 5.49 | 23.62 | |
Divi's Laboratories | 6,030.50 | 1,60,090.83 | 14.63 | 18.85 | 0.00 | 1.47 | -9.55 | 69.42 | 11.67 | 44.96 | |
Cipla | 1,542.85 | 1,24,624.34 | 16.90 | 21.57 | 0.00 | 8.17 | 25.01 | 23.11 | 4.39 | 14.50 | |
Torrent Pharmaceuticals | 3,609.55 | 1,22,163.57 | 25.17 | 28.71 | 0.40 | 10.62 | 15.31 | 61.02 | 16.28 | 29.89 | |
Apollo Hospitals Enterprise | 7,801.00 | 1,12,166.41 | 17.60 | 15.32 | 0.64 | 14.12 | 23.83 | 71.28 | 14.95 | 30.91 | |
Max Healthcare Institute | 1,153.45 | 1,12,142.61 | 11.46 | 12.27 | 0.27 | 21.37 | 23.24 | 97.73 | 12.74 | 54.09 | |
Mankind Pharma | 2,578.60 | 1,06,433.90 | 13.89 | 13.27 | 0.59 | 16.19 | 11.57 | 56.23 | 10.07 | 30.42 | |
Dr. Reddy's Laboratories | 1,250.35 | 1,04,355.12 | 16.85 | 21.81 | 0.12 | 14.86 | 37.35 | 18.37 | 3.39 | 10.11 | |
Zydus Lifesciences | 1,009.15 | 1,01,544.10 | 18.89 | 22.77 | 0.13 | 15.04 | 2.75 | 22.15 | 4.65 | 12.52 | |
Lupin | 1,945.20 | 88,847.89 | 19.07 | 21.29 | 0.30 | 11.45 | 29.02 | 24.02 | 5.68 | 17.26 | |
Fortis Healthcare | 942.70 | 71,169.90 | 8.68 | 10.50 | 0.25 | 10.83 | 53.22 | 81.95 | 9.07 | 33.04 | |
Abbott India | 30,940.00 | 65,745.34 | 33.41 | 42.09 | 0.00 | 9.22 | 20.99 | 45.27 | 15.53 | 32.32 | |
Alkem Laboratories | 5,322.50 | 63,638.47 | 18.06 | 19.29 | 0.09 | 6.83 | 9.25 | 27.86 | 5.54 | 19.39 | |
Aurobindo Pharma | 1,040.25 | 60,417.89 | 10.67 | 15.82 | 0.24 | 10.59 | 7.88 | 17.82 | 1.96 | 9.31 | |
Glenmark Pharmaceuticals | 2,050.80 | 57,873.74 | 11.83 | 19.62 | 0.25 | 2.68 | 5.69 | 76.79 | 6.85 | 17.83 | |
Biocon | 363.85 | 48,645.42 | 4.68 | 6.04 | 0.82 | 23.09 | 6.48 | 126.36 | 2.31 | 13.87 | |
Laurus Labs | 895.90 | 48,362.91 | 8.01 | 11.82 | 0.60 | 4.01 | -24.35 | 95.05 | 10.81 | 32.07 | |
GlaxoSmithKline Pharmaceuticals | 2,811.40 | 47,626.81 | 47.67 | 57.03 | 0.00 | 4.58 | -18.15 | 50.12 | 28.47 | 35.77 | |
Anthem Biosciences | 819.95 | 46,049.22 | 18.72 | 26.88 | 0.05 | NM | NM | 0.00 | 19.10 | 0.00 | |
Cohance Lifesciences | 1,011.20 | 38,685.19 | 15.78 | 13.36 | 0.05 | -3.20 | -16.11 | 151.13 | 22.63 | 68.38 | |
Global Health | 1,392.55 | 37,430.40 | 14.21 | 18.38 | 0.10 | -5.01 | 39.39 | 70.07 | 11.91 | 32.83 | |
Narayana Hrudayalaya | 1,783.60 | 36,449.79 | 21.80 | 17.95 | 0.61 | 14.00 | 31.59 | 46.41 | 11.37 | 26.40 | |
Ipca Laboratories | 1,319.30 | 33,471.20 | 10.61 | 15.15 | 0.19 | 15.32 | 2.16 | 42.99 | 5.00 | 22.26 | |
Aster DM Healthcare | 635.40 | 32,921.41 | 156.87 | 11.59 | 0.19 | -26.10 | 117.71 | 103.49 | 9.53 | 25.97 | |
Ajanta Pharma | 2,579.65 | 32,222.95 | 24.28 | 30.10 | 0.00 | 11.63 | 8.90 | 34.65 | 8.76 | 24.11 |
The largest company, by revenues, in the Pharmaceuticals and health care sector is Sun Pharmaceutical Industries. Its revenues for the most recent year ended is Rs 52,578.44 cr.
Sun Pharmaceutical Industries has a market capitalisation of Rs 3,79,478.82 cr. Over the previous 12 months, Sun Pharmaceutical Industries’s share price declined 13.26%.
You can get the latest share price and detailed financials of Sun Pharmaceutical Industries here.
Also, you can see the latest share price performance of all pharmaceuticals and health care stocks here.
Disclaimer: Analysis and Recommendations are provided by various stock brokerage firms and from various Stock Market Experts. Financialexpress.com's/IE Online Media Services Pvt. Ltd (IEOMSPL) does not provide individual or customized investment services.
Since each individual's situation is unique, a qualified professional should be consulted before making financial decisions.
Financialexpress.com / IEOMSPL makes no guarantees as to the accuracy, thoroughness, or quality of the information provided, which is provided only on an “AS AVAILABLE” basis at visitor's sole risk. Financialexpress.com/IEOMSPL shall not be responsible or liable for any errors, omissions or inaccuracies in the content. The information and investment, accounting, or legal information provided here are neither comprehensive nor appropriate for every individual. The visitor is advised to verify any information before using it for any personal, financial, accounting, legal, or business purpose. In addition, the opinions and views expressed in any article on Financialexpress.com's/ IEOMSPL are solely those of the author(s) of the article received as is from Stock Brokerage Firm and Stock Market Experts and do not reflect the opinions of financialexpress.com/IEOMSPL or its management. Financialexpress.com/ IEOMSPL 's content herein may be modified at any time by us, without advance notice or reason, and financialexpress.com/IEOMSPL shall have no obligation to notify you of any corrections or changes to any Site content.
Read More
This screener helps you discover companies focused on essential medicines and health services.
Indian firms export generics and specialty drugs to regulated markets like the US and EU.
Pharma, diagnostics, and hospitals meet everyday healthcare needs in India.
Companies with FDA and WHO approvals benefit from credibility and higher margins.
Stocks span pharma, biotech, diagnostics, insurance, and hospitals.
Generic drugs are off-patent versions of branded medicines with the same composition.
Approval from the US FDA allows Indian companies to export and sell drugs in the US.
Pharmaceuticals, diagnostics, hospitals, medical devices, and insurance all fall under healthcare.